Concert Pharmaceuticals to Report First Quarter 2020 Financial Results on April 30, 2020
April 23 2020 - 7:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will report its first quarter 2020 financial results on
Thursday, April 30, 2020, before the U.S. financial markets open.
The Company will host a conference call and webcast at 8:30 a.m. ET
to discuss first quarter financial results and provide a business
update. Individuals interested in participating in the call should
dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865
(International).
A live webcast of the first quarter financial results may be
accessed in the Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the first quarter financial results webcast will be
available on Concert’s website for three months.
About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company focused on applying its DCE Platform® (deuterated chemical
entity platform) to create novel medicines designed to treat
serious diseases and address unmet patient needs. The Company’s
approach starts with previously studied compounds, including
approved drugs, in which deuterium substitution has the potential
to enhance clinical safety, tolerability or efficacy. Concert’s
pipeline of innovative medicines targets autoimmune diseases and
central nervous systems (CNS) disorders. For more information
please visit www.concertpharma.com or follow us on Twitter at
@ConcertPharma or on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200423005034/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Jul 2023 to Jul 2024